Common use of Quarterly Reporting Template Clause in Contracts

Quarterly Reporting Template. Each Reporting Template shall include the following but may be subject to change from time to time: Reporting Template for Royalties Cou ntry Local Curr ency (LC) Custom xx Xxxxx revenue from Sale of Licensed Products (in LC) Allow able Deduction s (in LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized detail of details against gross sales to compute net sales (LC) Excha nge Rate (USD per LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized Detail of details against gross Sales to compute net sales (LC) Royalty Rate Total Royalties due to Pfizer E.g. India INR Gov. Entities/ Public Purchas ers 80,000,0 00 5,000,0 00 75,000,000 0.0133 1,000,000 5% 50,000 INR Commer cial Entities 20,000,0 00 1,000,000 19,000,000 0.0133 253,333.33 10% 25,333.33 Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Licensed Products Country Licensed Product manufactured and sold Strength Formulation (Tablet/granules /liquid/powder for suspension) Pack Size Quantity (number of packs) Total Value in USD (FOB)* Country of Origin * Please mention FOB (Free on Board) price basis country of origin Note: this format is to be filled and sent to MPP on a quarterly basis, 10 Business days from end of each calendar quarter. Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Compounds Month Country Purchaser Licensed Product Quantity (kg) Total Value (USD)

Quarterly Reporting Template. Each Reporting Template shall include the following but may be subject to change from time to time: Reporting Template for Royalties Cou ntry Local Curr ency (LC) Custom xx Xxxxx revenue from Sale of Licensed Products (in LC) Allow able Deduction s (in LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized detail of details against gross sales to compute net sales (LC) Excha nge Rate (USD per LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized Detail of details against gross Sales to compute net sales (LC) Royalty Rate Total Royalties due to Pfizer E.g. India INR Gov. Entities/ Public Purchas ers 80,000,0 00 5,000,0 00 75,000,000 0.0133 1,000,000 5% 50,000 INR Commer cial Entities 20,000,0 00 1,000,000 19,000,000 0.0133 253,333.33 10% 25,333.33 Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Licensed Products Country Licensed Product manufactured and sold Strength Formulation (Tablet/granules /liquid/powder for suspension) Pack Size Quantity (number of packs) Total Value in USD (FOB)* Country of Origin * Please mention FOB (Free on Board) price basis country of origin Note: this format is to be filled and sent to MPP on a quarterly basis, 10 Business days from end of each calendar quarter. Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: _ Date: _ Title: Reporting Template for Compounds Month Country Purchaser Licensed Product Quantity (kg) Total Value (USD)

Quarterly Reporting Template. Each Reporting Template shall include the following but may be subject to change from time to time: Reporting Template for Royalties Cou ntry Local Curr ency (LC) Custom xx Xxxxx revenue from Sale of Licensed Products (in LC) Allow able Deduction s (in LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized detail of details against gross sales to compute net sales (LC) Excha nge Rate (USD per LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized Detail of details against gross Sales to compute net sales (LC) Royalty Rate Total Royalties due to Pfizer E.g. India INR Gov. Entities/ Public Purchas ers 80,000,0 00 5,000,0 00 75,000,000 0.0133 1,000,000 5% 50,000 INR Commer cial Entities 20,000,0 00 1,000,000 19,000,000 0.0133 253,333.33 10% 25,333.33 Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Licensed Products Country Licensed Product manufactured and sold Strength Formulation (Tablet/granules /liquid/powder for suspension) Pack Size Quantity (number of packs) Total Value in USD (FOB)* Country of Origin * Please mention FOB (Free on Board) price basis country of origin Note: this format is to be filled and sent to MPP on a quarterly basis, 10 Business days from end of each calendar quarter. Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: DocuSign Envelope ID: F0C62F1B-BD77-4D06-9219-67924AA8E188 Reporting Template for Compounds Month Country Purchaser Licensed Product Quantity (kg) Total Value (USD)

Quarterly Reporting Template. Each Reporting Template shall include the following but may be subject to change from time to time: Reporting Template for Royalties Cou ntry Local Curr ency (LC) Custom xx Xxxxx revenue from Sale of Licensed Products (in LC) Allow able Deduction s (in LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized detail of details against gross sales to compute net sales (LC) Excha nge Rate (USD per LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized Detail of details against gross Sales to compute net sales (LC) Royalty Rate Total Royalties due to Pfizer E.g. India INR Gov. Entities/ Public Purchas ers 80,000,0 00 5,000,0 00 75,000,000 0.0133 1,000,000 5% 50,000 INR Commer cial Entities 20,000,0 00 1,000,000 19,000,000 0.0133 253,333.33 10% 25,333.33 Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Licensed Products Country Licensed Product manufactured and sold Strength Formulation (Tablet/granules /liquid/powder for suspension) Pack Size Quantity (number of packs) Total Value in USD (FOB)* Country of Origin * Please mention FOB (Free on Board) price basis country of origin Note: this format is to be filled and sent to MPP on a quarterly basis, 10 Business days from end of each calendar quarter. Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: DocuSign Envelope ID: 20ED8EAA-71E5-4C18-B49D-62DBEC763D25 Reporting Template for Compounds Month Country Purchaser Licensed Product Quantity (kg) Total Value (USD)

Quarterly Reporting Template. Each Reporting Template shall include the following but may be subject to change from time to time: Reporting Template for Royalties Cou ntry Local Curr ency (LC) Custom xx Xxxxx revenue from Sale of Licensed Products (in LC) Allow able Deduction s (in LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized detail of details against gross sales to compute net sales (LC) Excha nge Rate (USD per LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized Detail of details against gross Sales to compute net sales (LC) Royalty Rate Total Royalties due to Pfizer E.g. India INR Gov. Entities/ Public Purchas ers 80,000,0 00 5,000,0 00 75,000,000 0.0133 1,000,000 5% 50,000 INR Commer cial Entities 20,000,0 00 1,000,000 19,000,000 0.0133 253,333.33 10% 25,333.33 Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Licensed Products Country Licensed Product manufactured and sold Strength Formulation (Tablet/granules /liquid/powder for suspension) Pack Size Quantity (number of packs) Total Value in USD (FOB)* Country of Origin * Please mention FOB (Free on Board) price basis country of origin Note: this format is to be filled and sent to MPP on a quarterly basis, 10 Business days from end of each calendar quarter. DocuSign Envelope ID: B1AB13C2-5EBB-410E-B336-02154B8CAD03 Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Compounds Month Country Purchaser Licensed Product Quantity (kg) Total Value (USD)

Quarterly Reporting Template. Each Reporting Template shall include the following but may be subject to change from time to time: Reporting Template for Royalties Cou ntry Local Curr ency (LC) Custom xx Xxxxx revenue from Sale of Licensed Products Pro d uc t s (in LC) Allow able Deduction s (in LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized detail of details against gross sales to compute net sales (LC) Excha nge Rate (USD per LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized Detail of details against gross Sales to compute net sales (LC) Royalty Rate Total Royalties due to Pfizer detail of Detail of details details against against gross sales gross Sales to compute to compute net sales net sales ( LC) ( LC) E.g. India INR Gov. Entities/ Public Purchas ers 80,000,0 00 5,000,0 00 75,000,000 0.0133 1,000,000 5% 50,000 INR Commer cial Entities 20,000,0 00 1,000,000 19,000,000 0.0133 253,333.33 10% 25,333.33 Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (( as defined in the License Agreement)) , including, without limitation, with respect to anti-anti- corruption, anti-anti- competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Licensed Products Country Licensed Product Pro duct manufactured and sold Strength Formulation (Tablet/Formula t ion ( Tablet/ granules /liquid// liquid/ powder for suspension) Pack Size Quantity (( number of packs) Total Value in USD (FOB)* Country of Origin * Please mention FOB (( Free on Board) price basis country of origin Note: this format is to be filled and sent to MPP on a quarterly basis, 10 1 0 Business days from end of each calendar quarter. Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (( as defined in the License Agreement)) , including, without limitation, with respect to anti-anti- corruption, anti-anti- competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Compounds Month Country Purchaser Licensed Product Quantity (kg) Total Value (USD)

Quarterly Reporting Template. Each Reporting Template shall include the following but may be subject to change from time to time: Reporting Template for Royalties Cou ntry Local Curr ency (LC) Custom xx Xxxxx revenue from Sale of Licensed Products (in LC) Allow able Deduction s (in LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized detail of details against gross sales to compute net sales (LC) Excha nge Rate (USD per LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized Detail of details against gross Sales to compute net sales (LC) Royalty Rate Total Royalties Royaltie s due to Pfizer E.g. India INR Gov. Entities/ Public Purchas ers 80,000,0 00 5,000,0 00 75,000,000 0.0133 1,000,000 5% 50,000 INR ers Commer cial Entities 20,000,0 00 1,000,000 19,000,000 0.0133 253,333.33 10% 25,333.33 Entities Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: :_ Title: :_ Reporting Template for Licensed Products Country Licensed Product manufactured and sold Strength Formulation (Tablet/granules /liquid/powder for suspension) Pack Size Quantity (number of packs) Total Value in USD (FOB)* Country of Origin * Please mention FOB (Free on Board) price basis country of origin Note: this format is to be filled and sent to MPP on a quarterly basis, 10 Business days from end of each calendar quarter. Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Compounds Month Country Purchaser Licensed Product Quantity (kg) Total Value (USD).

Quarterly Reporting Template. Each Reporting Template shall include the following but may be subject to change from time to time: Reporting Template for Royalties Cou ntry Local Curr ency (LC) Custom xx Xxxxx revenue from Sale of Licensed Products (in LC) Allow able Deduction s (in LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized detail of details against gross sales to compute net sales (LC) Excha nge Rate (USD per LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized Detail of details against gross Sales to compute net sales (LC) Royalty Rate Total Royalties due to Pfizer E.g. India INR Gov. Entities/ Public Purchas ers 80,000,0 00 5,000,0 00 75,000,000 0.0133 1,000,000 5% 50,000 INR Commer cial Entities 20,000,0 00 1,000,000 19,000,000 0.0133 253,333.33 10% 25,333.33 Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Licensed Products Country Licensed Product manufactured and sold Strength Formulation (Tablet/granules /liquid/powder for suspension) Pack Size Quantity (number of packs) Total Value in USD (FOB)* Country of Origin * Please mention FOB (Free on Board) price basis country of origin Note: this format is to be filled and sent to MPP on a quarterly basis, 10 Business days from end of each calendar quarter. Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: DocuSign Envelope ID: 76B8C7A6-66D1-43C9-84E7-0D151DB61944 Reporting Template for Compounds Month Country Purchaser Licensed Product Quantity (kg) Total Value (USD)

Quarterly Reporting Template. Each Reporting Template shall include the following but may be subject to change from time to time: Reporting Template for Royalties Cou ntry Local Curr ency (LC) Custom xx Xxxxx revenue from Sale of Licensed Products (in LC) Allow able Deduction s (in LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized detail of details against gross sales to compute net sales (LC) Excha nge Rate (USD per LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized Detail of details against gross Sales to compute net sales (LC) Royalty Rate Total Royalties due to Pfizer E.g. India INR Gov. Entities/ Public Purchas ers 80,000,0 00 5,000,0 00 75,000,000 0.0133 1,000,000 5% 50,000 INR Commer cial Entities 20,000,0 00 1,000,000 19,000,000 0.0133 253,333.33 10% 25,333.33 Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Licensed Products Country Licensed Product manufactured and sold Strength Formulation (Tablet/granules /liquid/powder for suspension) Pack Size Quantity (number of packs) Total Value in USD (FOB)* Country of Origin * Please mention FOB (Free on Board) price basis country of origin Note: this format is to be filled and sent to MPP on a quarterly basis, 10 Business days from end of each calendar quarter. Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: DocuSign Envelope ID: 91216EB2-F486-414B-B694-F90CEB5F065E Reporting Template for Compounds Month Country Purchaser Licensed Product Quantity (kg) Total Value (USD)

Quarterly Reporting Template. Each Reporting Template shall include the following but may be subject to change from time to time: Reporting Template for Royalties Cou ntry Local Curr ency (LC) Custom xx Xxxxx revenue from Sale of Licensed Products (in LC) Allow able Deduction s (in LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized detail of details against gross sales to compute net sales (LC) Excha nge Rate (USD per LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized Detail of details against gross Sales to compute net sales (LC) Royalty Rate Total Royalties due to Pfizer E.g. India INR Gov. Entities/ Public Purchas ers 80,000,0 00 5,000,0 00 75,000,000 0.0133 1,000,000 5% 50,000 INR Commer cial Entities 20,000,0 00 1,000,000 19,000,000 0.0133 253,333.33 10% 25,333.33 Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Licensed Products Country Licensed Product manufactured and sold Strength Formulation (Tablet/granules /liquid/powder for suspension) Pack Size Quantity (number of packs) Total Value in USD (FOB)* Country of Origin * Please mention FOB (Free on Board) price basis country of origin Note: this format is to be filled and sent to MPP on a quarterly basis, 10 Business days from end of each calendar quarter. Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: DocuSign Envelope ID: D912197B-D81E-47C3-A57B-57CF17C9819B Reporting Template for Compounds Month Country Purchaser Licensed Product Quantity (kg) Total Value (USD)

Quarterly Reporting Template. Each Reporting Template shall include the following but may be subject to change from time to time: Reporting Template for Royalties Cou ntry Local Curr ency (LC) Custom xx Xxxxx revenue from Sale of Licensed Products (in LC) Allow able Deduction s (in LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized detail of details against gross sales to compute net sales (LC) Excha nge Rate (USD per LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized Detail of details against gross Sales to compute net sales (LC) Royalty Rate Total Royalties due to Pfizer E.g. India INR Gov. Entities/ Public Purchas ers 80,000,0 00 5,000,0 00 75,000,000 0.0133 1,000,000 5% 50,000 INR Commer cial Entities 20,000,0 00 1,000,000 19,000,000 0.0133 253,333.33 10% 25,333.33 Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Licensed Products Country Licensed Product manufactured and sold Strength Formulation (Tablet/granules /liquid/powder for suspension) Pack Size Quantity (number of packs) Total Value in USD (FOB)* Country of Origin * Please mention FOB (Free on Board) price basis country of origin Note: this format is to be filled and sent to MPP on a quarterly basis, 10 Business days from end of each calendar quarter. Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: DocuSign Envelope ID: E389DDA3-3EA0-4C1B-801D-93CD35BC54C2 Reporting Template for Compounds Month Country Purchaser Licensed Product Quantity (kg) Total Value (USD)

Quarterly Reporting Template. Each Reporting Template shall include the following but may be subject to change from time to time: Reporting Template for Royalties Cou Local Custom Gross Allow able Net Sales Excha Net Sales Royalty Total ntry Local Curr er revenue Deduction pursuant to nge pursuant to Rate Royalties ency (LC) Custom xx Xxxxx revenue from Sale of Licensed Products (in LC) Allow able Deduction s (in LC) Net Sales pursuant Section Rate Section due to Section (LC) of Licensed 1.21 of the (USD 1.21 of the Pfizer Products License per License (in LC) Agreement, LC) Agreement, itemized itemized detail of Detail of details details against against gross sales gross Sales to compute to compute net sales net sales (LC) Excha nge Rate (USD per LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized Detail of details against gross Sales to compute net sales (LC) Royalty Rate Total Royalties due to Pfizer E.g. India INR Gov. Entities/ Public Purchas ers 80,000,0 00 5,000,0 00 75,000,000 0.0133 1,000,000 5% 50,000 INR Commer cial Entities 20,000,0 00 1,000,000 19,000,000 0.0133 253,333.33 10% 25,333.33 Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Licensed Products Country Licensed Product manufactured and sold Strength Formulation (Tablet/granules /liquid/powder for suspension) Pack Size Quantity (number of packs) Total Value in USD (FOB)* Country of Origin * Please mention FOB (Free on Board) price basis country of origin Note: this format is to be filled and sent to MPP on a quarterly basis, 10 Business days from end of each calendar quarter. Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Compounds Month Country Purchaser Licensed Product Quantity (kg) Total Value (USD)

Quarterly Reporting Template. Each Reporting Template shall include the following but may be subject to change from time to time: Reporting Template for Royalties Cou ntry Local Curr ency (LC) Custom xx Xxxxx revenue from Sale of Licensed Products (in LC) Allow able Deduction s (in LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized detail of details against gross sales to compute net sales (LC) Excha nge Rate (USD per LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized Detail of details against gross Sales to compute net sales (LC) Royalty Rate Total Royalties due to Pfizer E.g. India INR Gov. Entities/ Public Purchas ers 80,000,0 00 5,000,0 00 75,000,000 0.0133 1,000,000 5% 50,000 INR Commer cial Entities 20,000,0 00 1,000,000 19,000,000 0.0133 253,333.33 10% 25,333.33 Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Licensed Products Country Licensed Product manufactured and sold Strength Formulation (Tablet/granules /liquid/powder for suspension) Pack Size Quantity (number of packs) Total Value in USD (FOB)* Country of Origin * Please mention FOB (Free on Board) price basis country of origin Note: this format is to be filled and sent to MPP on a quarterly basis, 10 Business days from end of each calendar quarter. Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: DocuSign Envelope ID: 174398E9-7BC6-4D69-97DC-01A43A37BFC6 Reporting Template for Compounds Month Country Purchaser Licensed Product Quantity (kg) Total Value (USD)

Quarterly Reporting Template. Each Reporting Template shall include the following but may be subject to change from time to time: Reporting Template for Royalties Cou ntry Local Curr ency (LC) Custom xx Xxxxx revenue from Sale of Licensed Products (in LC) Allow able Deduction s (in LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized detail of details against gross sales to compute net sales (LC) Excha nge Rate (USD per LC) Net Sales pursuant to Section 1.21 of the License Agreement, itemized Detail of details against gross Sales to compute net sales (LC) Royalty Rate Total Royalties due to Pfizer E.g. India INR Gov. Entities/ Public Purchas ers 80,000,0 00 5,000,0 00 75,000,000 0.0133 1,000,000 5% 50,000 INR Commer cial Entities 20,000,0 00 1,000,000 19,000,000 0.0133 253,333.33 10% 25,333.33 Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: Reporting Template for Licensed Products Country Licensed Product manufactured and sold Strength Formulation (Tablet/granules /liquid/powder for suspension) Pack Size Quantity (number of packs) Total Value in USD (FOB)* Country of Origin * Please mention FOB (Free on Board) price basis country of origin Note: this format is to be filled and sent to MPP on a quarterly basis, 10 Business days from end of each calendar quarter. Compliance Certification: I hereby certify that all activities performed under the License Agreement have been conducted in accordance with all Applicable Law (as defined in the License Agreement), including, without limitation, with respect to anti-corruption, anti-competition, recalls, safety and reporting requirements, and export controls and sanctions. Name: Date: Title: DocuSign Envelope ID: E68F63E3-D274-4CA3-9C96-ECE5CBD30F63 Reporting Template for Compounds Month Country Purchaser Licensed Product Quantity (kg) Total Value (USD)